3.
99例EGFR突变患者的单因素分析
Univariate analysis of PFS in 99 mutation patients
| Variables | PFS (months) | 95%CI | P |
| PFS: progression-free survival. | |||
| Age (year) | 0.545 | ||
| < 70 | 8.7 | 4.6-12.7 | |
| ≥70 | 16.0 | 9.0-22.9 | |
| Gender | 0.845 | ||
| Male | 10.5 | 4.0-16.9 | |
| Female | 11.6 | 3.9-19.2 | |
| Smoking characteristics | 0.348 | ||
| Yes | 7.0 | 0-16.5 | |
| No | 10.8 | 5.3-16.3 | |
| Performance status | 0.051 | ||
| 0-1 | 10.6 | 2.4-16.8 | |
| ≥2 | 10.0 | 2.8-18.2 | |
| Histology | 0.427 | ||
| Adenocarcinoma | 10.8 | 5.5-16.1 | |
| Non-adenocarcinoma | 4.0 | 2.4-5.6 | |
| Prior chemotherapy | 0.170 | ||
| 0 | 12.9 | 5.2-20.6 | |
| ≥1 | 7.5 | 1.8-13.2 | |